Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2023-06-30 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
关于第一期员工持股计划第二个锁定期届满的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the expiration of the second lock-up period of the company's first employee stock ownership plan. It includes information about the stock held under the plan, performance assessment results, subsequent arrangements, and potential changes or termination of the plan. The content focuses on employee stock ownership plan details, lock-up periods, performance targets, and distribution of proceeds. There is no indication that this is a full financial report, audit report, or earnings release. It is not a regulatory filing or a report publication announcement since it contains substantive information about the employee stock plan status and performance. The document is an announcement related to capital structure changes specifically concerning employee stock ownership plans and lock-up expirations. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-06-30 Chinese
2022年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as an announcement of the resolutions from the 2022 Annual General Meeting (AGM) of the company. It details the date and method of the meeting, attendance, and the voting results on various proposals including the 2022 Annual Report, financial statements, board reports, audit appointment, and profit distribution plan. The document does not contain the full annual report or financial statements themselves but rather the official voting results and confirmation of the meeting's legality and procedures. The document length is 3399 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-05-19 Chinese
北京市金杜律师事务所关于成都市贝瑞和康基因技术股份有限公司2022年年度股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2022 Annual General Meeting (AGM) of Chengdu Berry Genomics Co., Ltd. It details the procedures of the AGM, the qualifications of attendees, the voting process, and the voting results on various agenda items including the 2022 annual report, financial statements, board and supervisory reports, audit appointment, and profit distribution plan. The document does not contain the actual annual report or financial statements but rather confirms the legality and validity of the AGM process and voting outcomes. This type of document is typically classified as a Declaration of Voting Results & Voting Rights Announcements (DVA) because it officially reports the results of shareholder votes at the AGM. The document length (6952 characters) and content confirm it is not merely an announcement of a report publication but a detailed legal opinion on the AGM voting results. Therefore, the correct classification is DVA with high confidence.
2023-05-19 Chinese
关于为控股子公司提供担保额度的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the progress of providing a guarantee for its controlling subsidiary. It details the guarantee amount, the subsidiary's financial data, the board's opinions, and compliance with relevant laws. The document is a formal public announcement about a financing-related guarantee arrangement rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis but focuses on the guarantee and credit support. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company financing activities and guarantees.
2023-05-15 Chinese
2023年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "成都市贝瑞和康基因技术股份有限公司2023 年第一季度报告" which translates to "Chengdu Berry Genomics Co., Ltd. 2023 First Quarter Report." It contains detailed financial data including balance sheets, income statements, cash flow statements, and shareholder information for the first quarter of 2023. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the period ending March 31, 2023. It also mentions that the report is unaudited. The length of the document (11,872 characters) and the detailed financial content confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-04-28 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from the company regarding the approval of the 2023 first quarter report. It states that the board meeting was held, the report was approved, and the detailed report is published elsewhere (on various newspapers and a website). The document itself does not contain the financial report or substantive financial data but is an announcement of the board's resolution and reference to the actual quarterly report. The document length is short (630 characters), and it serves as a formal announcement of the board meeting decision rather than the report itself. Therefore, it fits best under Board/Management Information (MANG) as it relates to board meeting resolutions and decisions.
2023-04-28 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.